T he past several decades have been marked by dramatic advances in the management of patients with an acute decompensation of ischemic heart disease. A now common phrase in our clinical lexicon is acute coronary syndrome, which is further subdivided into presentations with and without ST-segment elevation on the ECG, thus dividing acute coronary syndrome presentations into ST-segment elevation myocardial infarction (STEMI) and unstable angina/ non-ST-segment myocardial infarction (MI).
1 Given the time urgency of restoring antegrade flow in the culprit coronary artery in STEMI, it is understandable that a major focus of clinical research has been defining the optimal reperfusion regimen, first with fibrinolysis and later with catheter-based interventions.
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In 2006, an American Heart Association (AHA) Consensus Statement was published outlining the fact that, at the time, only a minority of patients with STEMI in the United States received primary percutaneous coronary intervention (PCI) and, in those who did, <40% were treated within 90 minutes after hospital arrival. 2 The AHA convened an acute MI Advisory Working Group that agreed that the next step in the process after the initial consensus statement was to develop an implementation plan to establish a system of care to increase the number of patients with STEMI who received timely access to primary PCI. Within a year, a conference was held with representation from all the key stakeholders, the success of early model STEMI systems was reviewed, and the AHA launched Mission:Lifeline, an initiative to improve the quality of care and outcomes for patients with STEMI and to improve the healthcare system readiness and response to STEMI. 3 Several remarkable achievements of Mission:Lifeline over the past 6 years are worth noting. A robust Website exists that is the central clearing house to learn more about Mission:Lifeline, get the latest news on hot topics, access tools and resources, and register/locate a system of care for STEMI. 4 As of June 2013, a total of 680 STEMI systems were registered across the United States, covering 67% of our nation's population.
In an earlier report published in 2012, when 381 unique systems involving 899 PCI hospitals from 47 states responded to a survey via the Mission:Lifeline Website, the organizational characteristics of the collaborative efforts to provide timely reperfusion for STEMI in the United States were summarized. 5 Of note, at the time, 55% of systems reported the availability of 12-lead ECGs in their emergency medical system (EMS) vehicles. The 12-lead ECG was transmitted to a hospital in 68% of the systems. Interpretation of the tracing was performed by paramedics in 63% and by computer in 34% of systems. When the prehospital ECG revealed a STEMI, the catheterization laboratory was activated via emergency department (ED) notification in 78% of systems; 19% involved a cardiologist for activation and 15% permitted an emergency medical technician to activate the laboratory directly.
In a complementary quality improvement effort, the American College of Cardiology initiated the Door-to-Balloon (D2B) Alliance in 2006 to improve door-to-device times in PCI-capable hospitals caring for patients with STEMI. 6 The National Cardiovascular Data Registry CathPCI Registry was used as the data collection tool for the D2B Alliance. The goal was for participating hospitals to treat 75% of their nontransfer STEMI patients within ≤90 minutes of hospital arrival. Hospitals participating in the D2B quality improvement project did show progressive increases in the proportion of patients treated within 90 minutes with the attainment of the 75% goal by 2009. 7 To examine national trends in D2B, in particular, asking whether improvements were noted in hospitals outside of registry settings, data submitted to the Centers for Medicare and Medicaid Services from 2005 through 2010 were analyzed. The median hospital D2B declined from 97 minutes in 2005 to 64 minutes in 2010. 8 Because time is muscle, it is a reasonable question to ask whether there are any components of the system delay that can be minimized to help shorten the time to reperfusion. In this issue, Bagai and colleagues 9 provide a report from Mission:Lifeline on 12 581 STEMI patients. The data were collected from hospitals in the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines (ACTION REGISTRY-GWTG) program. The analysis focused on STEMI patients with a prehospital ECG who were transported by EMS directly to a PCI-capable hospital. The purpose of the study was to evaluate the frequency of bypassing the ED and admitting the patient directly to the catheterization laboratory. Despite the shortening of first medical contact to device time associated with ED bypass, there was no difference in the adjusted in-hospital mortality in comparison with ED evaluation. How can we reconcile the fact that ED bypass was associated with a lower system delay but did not translate into improved in-hospital outcomes? Terkelsen et al 10 report from Western Denmark (55% of that nation's population) that between 2002 and 2008, a total of 6209 STEMI patients were admitted for primary PCI at 1 of 3 high-volume PCI centers, in 95% of cases being transported by a single EMS system. They found that for every 1-hour increase in system delay, the hazard ratio for long-term mortality (median follow-up of 3.4 years) in Cox regression analysis was 1.10 (1.04-1.16), P=0.002. It is possible that the lack of a signal of mortality benefit from ED bypass in the report from Bagai was from too small an impact of system delay (30 minutes) and too short a follow-up period (in-hospital outcomes).
Other epidemiological considerations may also confound the ability to detect a signal of the benefit of ED bypass. Those who were selected for ED bypass in the report from Bagai tended to have less complicated STEMI presentations, were likely to have a lower mortality risk, and were therefore less likely to show a benefit of ED bypass after adjusting for risk factors that drive mortality or excluding patients with heart failure/shock or nonsystem reasons for delay. 9 A dissociation between changes in components of system delay and in-hospital mortality has also been reported for D2B. Wang et al 11 examined data from 101 hospitals in the GWTG program between 2005 and 2007. Although D2B times decreased from 101 to 87 minutes, in-hospital mortality was not significantly changed (5.1% versus 4.7%; P=0.09). There was no correlation between changes in D2B time and composite quality measures. They speculate that a singular focus on 1 measure such as D2B may have crowded out attention to other aspects of hospital care that bear on mortality. Another consideration comes from a National Cardiovascular Data Registry report by Rathore et al 12 who analyzed the relationship between D2B time and in-hospital mortality in 43 801 patients with STEMI treated with primary PCI. The D2B-mortality relationship is relatively flat between 45 and 105 minutes of D2B time and then rises more sharply as D2B increases progressively to >105 minutes. Thus, the shortening of D2B time by 13 minutes from 101 to 87 minutes will have less of an impact than the shortening of D2B time from a higher baseline.
What are we to do with all this information, and what are the next big steps for improving systems of care for STEMI?
1. Focusing on a single component of system delay such as D2B or redefining the door by bypassing the ED is useful as a performance measure for PCI-capable centers, but it is not a sufficient measure for improving an overall system's performance in caring for STEMI patients. 10 Comprehensive care improvement programs that address all steps between admission and discharge after STEMI are needed to ensure that evidence-based therapies are delivered. 2. Continued focus on the expansion and refinement of systems of care for STEMI patients is a high priority and is emphasized in the most recent American College of Cardiology/AHA STEMI guidelines. 13 It would be highly desirable to see greater coordination among the many disparate EMS systems around the United States that care for STEMI patients. Mission:Lifeline is a logical quality improvement platform on which a much more organized prehospital network could be engrafted. This would be facilitated if STEMI and out-of-hospital cardiac events were mandated reportable events to public health authorities. 3. Ultimately, we need to see a reduction in total ischemic time, which involves recognition of STEMI symptoms by patients. 14 Every healthcare provider needs to make each office visit with a patient who has or is at risk for ischemic heart disease a teachable moment to review and rehearse the appropriate actions to be taken when the symptoms of STEMI appear. The American Heart Association is actively assisting clinicians and patients in this regard through its educational Website "Warning Signs of a Heart Attack" (http:// www.heart.org/HEARTORG/Conditions/HeartAttack/ WarningSignsofaHeartAttack/Warning-Signs-of-aHeart-Attack_UCM_002039_Article.jsp). Even the best organized system will not work effectively if patients delay in recognizing their symptoms and 50% of STEMI patients are not transported by EMS.
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